(Q39411419)

English

Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge

scientific article published on 24 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Cytomegalovirus

0 references

0 references

4

object named as

Quanjiao Chen

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Huadong Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yanfeng Yao

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chaoyang Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jianjun Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ze Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

24 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Virologica Sinica

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

174-182

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

https://scigraph.springernature.com/pub.10.1007/s12250-013-3330-9

0 references

Gene transfer into muscle by electroporation in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Cytomegalovirus: pathogen, paradigm, and puzzle

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus virion proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/nuclear export protein and overexpression of its GLFG repeat domain can inhibit virus propagation

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Murine cytomegalovirus inactivated by sodium periodate is innocuous and immunogenic in mice and protects them against death and infection

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

The 2001 Garrod lecture. The treatment of cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus vaccine: time to look for alternative options.

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Why is cytomegalovirus the most frequent cause of congenital infection?

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects.

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Vaccine prevention of maternal cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Progress toward an elusive goal: current status of cytomegalovirus vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Update on the current status of cytomegalovirus vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Viral and host control of cytomegalovirus maturation

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Vaccine strategies against human cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Human cytomegalovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3330-9

21 January 2018

Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mouse model for cytomegalovirus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23715998

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12250-013-3330-9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39411419&oldid=1873407647"